Skip to Content

Oleptro FDA Approval History

FDA Approved: Yes (Discontinued) (First approved February 2, 2010)
Brand name: Oleptro
Generic name: trazodone
Dosage form: Extended Release Tablets
Company: Labopharm Inc.
Treatment for: Depression

Marketing Status: Discontinued

Oleptro (trazodone) is a once-daily serotonin antagonist reuptake inhibitor (SARI) formulation for the treatment of major depressive disorder (MDD) in adults.

Development Timeline for Oleptro

DateArticle
Feb  2, 2010ApprovalLabopharm Receives FDA Approval for Oleptro
Nov 24, 2008Labopharm's NDA for Novel Trazodone Formulation Accepted for Review by FDA
Sep 22, 2008Labopharm Submits New Drug Application to FDA for DDS-04A to Treat Major Depression

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.